Home  /  Webcasts  /  surveillance, Surveillance Advances  /  CANCOVID-Preg: A Pan-Canadian Surveillance Program of Outcomes for Pregnant Women and People and their Infants who Acquired COVID-19 in Pregnancy.

CANCOVID-Preg: A Pan-Canadian Surveillance Program of Outcomes for Pregnant Women and People and their Infants who Acquired COVID-19 in Pregnancy.

Introduction

This presentation will provide an overview of the findings from CANCOVID-Preg, a pan-Canadian surveillance program of SARS-CoV-2 infection in pregnancy. CANCOVID-Preg includes data on >40,000 pregnancies in Canada from 2020-2022 that were impacted by COVID-19 and was utilized over the course of the pandemic to guide public health and vaccination recommendations. With this data, we have described the impact on maternal and infant health associated with SARS-CoV-2 infection in pregnancy, elucidated the relationship between SARS-CoV-2 variants and maternal, pregnancy, and infant outcomes, and demonstrated the protective effect of vaccination in each variant period.

Hosted by: The Public Health Agency of Canada (PHAC)’s Data, Surveillance and Foresight Branch (DSFB) and National Collaborating Centre for Infectious Diseases (NCCID).

Date and time: March 25, 2025 | 1:00 to 2:00 Eastern Time / 12:00 to 1:00 Central Time

Language: English

Click here to register for the seminar

Introduction

Please join us on Tuesday, March 25, 2025 1:00 to 2:00 ET (10:00 to 11:00 PT), for the sixth seminar of the 2024-2025 Surveillance Advances season, “CANCOVID-Preg: A Pan-Canadian Surveillance Program of Outcomes for Pregnant Women and People and their Infants who Acquired COVID-19 in Pregnancy.” Led by Dr. Deborah Money.

This presentation will provide an overview of the findings from CANCOVID-Preg, a pan-Canadian surveillance program of SARS-CoV-2 infection in pregnancy. CANCOVID-Preg includes data on >40,000 pregnancies in Canada from 2020-2022 that were impacted by COVID-19 and was utilized over the course of the pandemic to guide public health and vaccination recommendations. With this data, we have described the impact on maternal and infant health associated with SARS-CoV-2 infection in pregnancy, elucidated the relationship between SARS-CoV-2 variants and maternal, pregnancy, and infant outcomes, and demonstrated the protective effect of vaccination in each variant period.

Learning Objectives

  1. To understand the impact of COVID-19 on pregnant women and people.
  2. To understand the impact of COVID-19 in pregnancy on the infant outcomes
  3. To understand the relationship between SARS-CoV-2 variant and maternal, pregnancy, and infant outcomes
  4. To understand the effect of vaccination on the impact of COVID-19 on pregnant women and people and their infants.

Speaker

1. Dr. Deborah Money, CM, BSc, MD, FRCSC, FCAHS, Professor & Head, Department of Obstetrics & Gynaecology, Dr. Victor Gomel Professor of Obstetrics & Gynaecology University of British Columbia, Clinician Scientist, Women’s Health Research Institute Chair, Infections in Pregnancy Committee, FIGO                                                                                  

Dr. Deborah Money is Professor and Head of the Department of Obstetrics and Gynecology, at the University of British Columbia (UBC).  She is a clinician/scientist in Reproductive Infectious Diseases, based at the Women’s Health Research Institute, leading several large multicentered research projects in the vaginal microbiome, HIV in pregnancy, HPV vaccine in women living with HIV, and syphilis in pregnancy. Since March 2020, she pivoted her research group to lead three large pan-Canadian projects to study the impact of COVID-19 on pregnant women and their infants and is now studying syphilis in pregnancy.  

She is the Chair of the Infections in Pregnancy committee for the International Federation of Gynecology and Obstetrics (FIGO). She has been a successful teacher, mentor and research team builder and has published more than 250 peer reviewed publications.  

She has received several awards including the Queen Elisabeth II, Diamond Jubilee Medal (2012), the Lifetime Achievement Award from the US based, Infectious Diseases Society of Obstetrics and Gynecology (2019), inducted as a Fellow of the Canadian Academy of Health Sciences (2023) and was appointed as a Member of the Order of Canada in December 2023. 

She is on the Canadian Master’s 060 Field Hockey team for 2024. www.ridprogram.med.ubc.ca 

Moderators

  1. Robert Sager, NCCID
  2. Chia-Yu Lin, PHAC

Format

This seminar will be held on Zoom. The presentation will be 30 minutes followed by approximately 15 minutes for a discussion and question period from attendees. Presentation materials in English and French will be distributed through NCCID media channels.

Access Instructions

All instructions for the seminar series will be posted on the Zoom registration page and will be emailed to all registrants prior to the event.

Past Webinars

Surveillance Advances launched in September 2023 with a discussion about the foundational concepts of public health surveillance and the future opportunities that lie ahead. Subsequent seminars featured topics related to health inequalities (seminar 2),  data science (seminar 3),  maternal and newborn health (seminar 4), and injury surveillance (seminar 5). For a complete list of seminars and to view their recordings, please visit the Surveillance Advances webcasts page

Click here to visit the Surveillance Advances webcasts page and access seminar information and recordings

Accreditation Statement

Surveillance Advances is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. Surveillance Advances is also approved by the Council of Professional Experience for professional development hours for members of the Canadian Institute of Public Health Inspectors.